Physician profile
Erin L Talbert
NPI 1679925358
$495.34
in general payments reported to CMS, 2019-2025
9 companies · $67.12 in 2025
The $67.12 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $138 · 2022: $90.35 · 2023: $139 · 2024: $61.49 · 2025: $67.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $267.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $250.69 | 2021-2025 | Ozempic, Rybelsus |
| Dexcom, INC. | $69.70 | 2021-2023 | Dexcom G6 Transmitter |
| Edwards Lifesciences Corporation | $38.26 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Takeda Pharmaceuticals U.S.A., INC. | $34.58 | 2021 | |
| Exact Sciences Corporation | $33.52 | 2023-2024 | Cologuard Collection Kit |
| Amgen INC. | $22.06 | 2023 | Repatha, Otezla |
| Tactile Systems Technology INC | $17.84 | 2024 | Entre Plus, Flexitouch Plus |
| Pfizer INC. | $16.50 | 2022 | |
| Abbott Laboratories | $12.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Talbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.